Prevention of invasive group A streptococcal disease among household contacts of case-patients: is prophylaxis warranted? The Working Group on Prevention of Invasive Group A Streptococcal Infections
- PMID: 9555761
Prevention of invasive group A streptococcal disease among household contacts of case-patients: is prophylaxis warranted? The Working Group on Prevention of Invasive Group A Streptococcal Infections
Abstract
Objectives: The Centers for Disease Control and Prevention (CDC) convened a Working Group in October 1995 to summarize the data regarding the risk of invasive group A streptococcal (GAS) disease among household contacts of an index patient and the potential efficacy of chemoprophylaxis. This statement on chemoprophylaxis for prevention of subsequent cases among household contacts is intended for use by public health professionals and clinicians.
Participants: The CDC invited representatives of the American Academy of Pediatrics, the Council of State and Territorial Epidemiologists, the Hospital Infection Control Practice Advisory Committee, the Infectious Diseases Society of America, and experts from academia to participate.
Evidence: Data on the transmission of GAS and risk factors for severe infection were considered. Population-based surveillance data were used to estimate the risk of invasive GAS disease among household contacts of a case patient. The potential efficacy of chemoprophylaxis was considered using estimates of the efficacy of various regimens in eradicating pharyngeal carriage.
Consensus process: This document summarizes the data considered by the Working Group to develop its position. The consensus achieved by group discussion at the meeting was incorporated in a draft document, which was reviewed by all members and revised to include suggested changes.
Conclusions: The Working Group concluded that no definite recommendations can be made at this time regarding chemoprophylaxis for household contacts of persons with invasive GAS infection. More data are needed to assess the risk of subsequent cases and to determine an optimal regimen for chemoprophylaxis. Until such data are available, physicians and health departments should base decisions regarding chemoprophylaxis on their assessment of the risk associated with each individual case.
Comment in
-
Risk of invasive streptococcal disease.JAMA. 1998 Dec 2;280(21):1828. doi: 10.1001/jama.280.21.1828-a. JAMA. 1998. PMID: 9846773 No abstract available.
Similar articles
-
Prevention of invasive group A streptococcal disease among household contacts of case patients and among postpartum and postsurgical patients: recommendations from the Centers for Disease Control and Prevention.Clin Infect Dis. 2002 Oct 15;35(8):950-9. doi: 10.1086/342692. Epub 2002 Sep 26. Clin Infect Dis. 2002. PMID: 12355382
-
Household transmission of invasive group A Streptococcus infections in England: a population-based study, 2009, 2011 to 2013.Euro Surveill. 2017 May 11;22(19):30532. doi: 10.2807/1560-7917.ES.2017.22.19.30532. Euro Surveill. 2017. PMID: 28537550 Free PMC article.
-
Interim UK guidelines for management of close community contacts of invasive group A streptococcal disease.Commun Dis Public Health. 2004 Dec;7(4):354-61. Commun Dis Public Health. 2004. PMID: 15786581 Review.
-
Efficacy of antibiotic prophylaxis for intrafamilial transmission of group A beta-hemolytic streptococci.Pediatr Infect Dis J. 2007 Feb;26(2):139-41. doi: 10.1097/01.inf.0000253060.72953.9d. Pediatr Infect Dis J. 2007. PMID: 17259876
-
QUESTION 1: Are household contacts of patients with invasive group A streptococcal disease at higher risk of secondary infection?Arch Dis Child. 2016 Feb;101(2):198-201. doi: 10.1136/archdischild-2015-309788. Arch Dis Child. 2016. PMID: 26792903 Review. No abstract available.
Cited by
-
Toxic shock syndrome in children: epidemiology, pathogenesis, and management.Paediatr Drugs. 2005;7(1):11-25. doi: 10.2165/00148581-200507010-00002. Paediatr Drugs. 2005. PMID: 15777108 Review.
-
Group A beta-hemolytic streptococcal bacteremia.Indian J Pediatr. 2004 Oct;71(10):915-9. doi: 10.1007/BF02830836. Indian J Pediatr. 2004. PMID: 15531835
-
Toxic Shock Syndrome (TSS) Caused by Group A Streptococcus: Novel Insights Within the Context of a Familiar Clinical Syndrome.J Korean Med Sci. 2024 May 6;39(17):e154. doi: 10.3346/jkms.2024.39.e154. J Korean Med Sci. 2024. PMID: 38711318 Free PMC article. Review.
-
Prophylactic antibiotics in children.Paediatr Child Health. 1999 Oct;4(7):490-502. doi: 10.1093/pch/4.7.490. Paediatr Child Health. 1999. PMID: 20212963 Free PMC article. No abstract available.
-
Group A Streptococcal Sepsis.Curr Infect Dis Rep. 2003 Oct;5(5):379-386. doi: 10.1007/s11908-003-0017-7. Curr Infect Dis Rep. 2003. PMID: 13678567 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical